What can GSK do to catch up with its global health care rivals?
It's been a tough few years for UK pharmaceutical giant GSK (GSK). Arguably the time is ripe for health care stocks. They enjoy decent pricing power, demand is relatively uncorrelated to a troubled global economy and margins are...
27 October 2022